Success stories

Our Success stories in 2017

Finished projects under fundraising process

Signed deals Sector Round size Year Investors
Oxolife Pharma project: Treatment of women infertility 5 M€ 2020 Inveready, CDTI, Capital Cell, Family Offices
Corify Care Medtech project: stratification of patients suffering from atrial fibrillation 1 M€ 2019 Family offices and EU funds
Apta Targets Pharma project: new aptamer for ischemic stroke 4,5 M€ 2017 Caixa Capital Risc and Inveready
Anaconda Medtech project: new catheter for thrombectomy 15 M€ 2017 Ysios, Omega, Innogest, Banc Sabadell
Peptomyc Biotech project: recombinant protein for NSCLC and TNBC 4,2 M€ 2017 ALTA Life Sciences and Healthequity
GlyCardial Diagnostics IVD project: new biomarker for cardiovascular ischemia 3,1 M€ 2017 Caixa Capital Risc and Healthequity

  • Pharma project: new drug to improve female fertility
  • 5 M€ raised in May 2020
  • Genesis consulting role: Fundraising & Suport
  • Investors: Inveready, CDTI, Capital Cell, Family Offices

  • Medtech project: stratification of patients suffering from atrial fibrillation
  • 1 M€ raised in January 2019
  • Genesis consulting role: Advisor and fundraiser
  • Investors: Family offices and EU funds

  • IVD project: new biomarker for cardiovascular ischemia
  • 2,4 M€ raised in October 2017
  • Genesis consulting role: Business Plan Development
  • Investors: Caixa Capital Risc and Healthequity

  • Biotech project: recombinant protein for NSCLC and TNBC
  • 4,2 M€ raised in July 2017
  • Genesis consulting role: Advisor
  • Investors: ALTA Life Sciences and Healthequity

Current projects under fundraising process

Company sector Product Indication Round size
Immunooncology Pharma Cancer 15M€
Cardiovascular Medtech Atrial fibrillation 3M€
Cardiovascular Medtech Vascular disease 8M€
Nephrology IVD Chronic kidney disease 800k€
Ophtalmology Medtech Cornea disorders 1M€